Hanmi’s ‘Olita Tab’ issue lead bill to tighten safety of clinical trial
While Hanmi Pharm’s Olita Tab encounter side effects of death during a clinical trial and is still causing issues, a bill to tighten safety of clinical trial was tabled.
On the 25th, The Minjoo Party Rep. Jung Park announced he tabled an amendment to the Pharmaceutical Affairs Law to obligate fo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
